HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ribonuclease 7 Shields the Kidney and Bladder from Invasive Uropathogenic Escherichia coli Infection.

AbstractBACKGROUND:
Evidence suggests that antimicrobial peptides, components of the innate immune response, protect the kidneys and bladder from bacterial challenge. We previously identified ribonuclease 7 (RNase 7) as a human antimicrobial peptide that has bactericidal activity against uropathogenic Escherichia coli (UPEC). Functional studies assessing RNase 7's contributions to urinary tract defense are limited.
METHODS:
To investigate RNase 7's role in preventing urinary tract infection (UTI), we quantified urinary RNase 7 concentrations in 29 girls and adolescents with a UTI history and 29 healthy female human controls. To assess RNase 7's antimicrobial activity in vitro in human urothelial cells, we used siRNA to silence urothelial RNase 7 production and retroviral constructs to stably overexpress RNase 7; we then evaluated UPEC's ability to bind and invade these cells. For RNase 7 in vivo studies, we developed humanized RNase 7 transgenic mice, subjected them to experimental UTI, and enumerated UPEC burden in the urine, bladder, and kidneys.
RESULTS:
Compared with controls, study participants with a UTI history had 1.5-fold lower urinary RNase 7 concentrations. When RNase 7 was silenced in vitro, the percentage of UPEC binding or invading human urothelial cells increased; when cells overexpressed RNase 7, UPEC attachment and invasion decreased. In the transgenic mice, we detected RNase 7 expression in the kidney's intercalated cells and bladder urothelium. RNase 7 humanized mice exhibited marked protection from UPEC.
CONCLUSIONS:
These findings provide evidence that RNase 7 has a role in kidney and bladder host defense against UPEC and establish a foundation for investigating RNase 7 as a UTI prognostic marker or nonantibiotic-based therapy.
AuthorsTad Eichler, Kristin Bender, Matthew J Murtha, Laura Schwartz, Jackie Metheny, Lindsey Solden, Robert M Jaggers, Michael T Bailey, Sudipti Gupta, Claudia Mosquera, Christina Ching, Krista La Perle, Birong Li, Brian Becknell, John David Spencer
JournalJournal of the American Society of Nephrology : JASN (J Am Soc Nephrol) Vol. 30 Issue 8 Pg. 1385-1397 (08 2019) ISSN: 1533-3450 [Electronic] United States
PMID31239387 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2019 by the American Society of Nephrology.
Chemical References
  • Anti-Bacterial Agents
  • Antimicrobial Cationic Peptides
  • Ribonucleases
  • Ribonuclease 7
Topics
  • Adolescent
  • Animals
  • Anti-Bacterial Agents (pharmacology)
  • Antimicrobial Cationic Peptides (genetics)
  • Child
  • Child, Preschool
  • Escherichia coli Infections (enzymology)
  • Female
  • Gene Silencing
  • Humans
  • Immunity, Innate
  • Infant
  • Kidney (enzymology, microbiology)
  • Male
  • Mice
  • Mice, Transgenic
  • Phenotype
  • Prognosis
  • Ribonucleases (genetics)
  • Urinary Bladder (enzymology, microbiology)
  • Urinary Tract Infections (enzymology, microbiology)
  • Uropathogenic Escherichia coli
  • Urothelium (metabolism, pathology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: